GLP-1 drugs go far beyond weight loss and show a surprising ability to tame cravings for everything from alcohol to gambling. Addiction scholar Carolina Haass-Koffler offers insight on how and why these drugs work and their potential for revolutionizing addiction treatment.
Understanding the very different characteristics of subgroups of obese patients may hold the key to devising more effective treatments and interventions, new research from Brown University found.
Accompanied by the island nation’s prime minister, Brown University public health professor Stephen McGarvey celebrated a new facility for studying the lifestyle and genetic influences of obesity and non-communicable diseases in Samoa.